Format
Sort by
Items per page

Send to

Choose Destination

Best matches for oncoscience[ta]:

Targeting RET-rearranged lung cancers with multikinase inhibitors. Sabari JK et al. Oncoscience. (2017)

Curing glioblastoma: oncolytic HSV-IL12 and checkpoint blockade. Saha D et al. Oncoscience. (2017)

Enhancing the antitumor potency of T cells redirected by bispecific antibodies. Chang CH et al. Oncoscience. (2017)

Search results

Items: 1 to 20 of 453

1.

Regression of primary cardiac angiosarcoma and metastatic nodules following propranolol as a single agent treatment.

Galván DC, Ayyappan AP, Bryan BA.

Oncoscience. 2018 Oct 11;5(9-10):264-268. doi: 10.18632/oncoscience.472. eCollection 2018 Sep.

2.

Reply to: Biological role of miR-204 and miR-211 in melanoma (published in Oncoscience, Vol 5 (7-8), July 2018).

Díaz-Martínez M, Benito-Jardón L, Alonso L, Teixidó J.

Oncoscience. 2018 Nov 9;5(9-10):262-263. doi: 10.18632/oncoscience.473. eCollection 2018 Sep. No abstract available.

3.

ETV4: an emerging target in pancreatic cancer.

Deshmukh SK, Singh AP, Singh S.

Oncoscience. 2018 Oct 11;5(9-10):260-261. doi: 10.18632/oncoscience.471. eCollection 2018 Sep. No abstract available.

4.

TP53 mutation status: emerging biomarker for precision radiation medicine?

Willers H, Wang M, Benes CH.

Oncoscience. 2018 Aug 28;5(9-10):258-259. doi: 10.18632/oncoscience.468. eCollection 2018 Sep. No abstract available.

5.

Risks and chances of aberrant DNA repair in cancer.

Schubert M, Greil R, Geisberger R.

Oncoscience. 2018 Aug 22;5(9-10):256-257. doi: 10.18632/oncoscience.459. eCollection 2018 Sep. No abstract available.

6.

Targeting PIM kinases to oppose hypoxia-mediated therapeutic resistance.

Chauhan SS, Warfel NA.

Oncoscience. 2018 Aug 22;5(9-10):254-255. doi: 10.18632/oncoscience.458. eCollection 2018 Sep. No abstract available.

7.

Re-thinking preclinical models of cancer metastasis.

Ullo MF, Logue JS.

Oncoscience. 2018 Aug 22;5(9-10):252-253. doi: 10.18632/oncoscience.450. eCollection 2018 Sep. No abstract available.

8.

Biological role of miR-204 and miR-211 in melanoma.

Vitiello M, D'Aurizio R, Poliseno L.

Oncoscience. 2018 Aug 22;5(7-8):248-251. doi: 10.18632/oncoscience.443. eCollection 2018 Jul.

9.

A survey of current surgical treatment of early stage breast cancer in China.

Zhang X, Wang Y.

Oncoscience. 2018 Aug 22;5(7-8):239-247. doi: 10.18632/oncoscience.445. eCollection 2018 Jul.

10.

Docetaxel increases the risk of severe infections in the treatment of non-small cell lung cancer: a meta-analysis.

Du Q, Jiang G, Li S, Liu Y, Huang Z.

Oncoscience. 2018 Aug 22;5(7-8):220-238. doi: 10.18632/oncoscience.444. eCollection 2018 Jul.

11.

BCL-2 inhibition is a promising therapeutic strategy for small cell lung cancer.

Lochmann TL, Bouck YM, Faber AC.

Oncoscience. 2018 Aug 14;5(7-8):218-219. doi: 10.18632/oncoscience.455. eCollection 2018 Jul. No abstract available.

12.

Proteomics of prostate cancer - revealing how cancer cells master their messy genomes.

Latonen L, Nykter M, Visakorpi T.

Oncoscience. 2018 Jul 31;5(7-8):216-217. doi: 10.18632/oncoscience.453. eCollection 2018 Jul. No abstract available.

13.

Attenuation of YAP1 can potentially target cancer stem cells to overcome drug resistance.

Harada K, Song S, Ajani JA.

Oncoscience. 2018 Aug 22;5(7-8):214-215. doi: 10.18632/oncoscience.449. eCollection 2018 Jul. No abstract available.

14.

Hemangioblast: origin of hemangioblastoma in von Hippel-Lindau (VHL) syndrome.

Wang H, Zhuang Z, Chan CC.

Oncoscience. 2018 Aug 22;5(7-8):212-213. doi: 10.18632/oncoscience.447. eCollection 2018 Jul. No abstract available.

15.

Role of circulating tumor DNA to help decision-making in hepatocellular carcinoma.

von Felden J, Craig AJ, Villanueva A.

Oncoscience. 2018 Aug 22;5(7-8):209-211. doi: 10.18632/oncoscience.446. eCollection 2018 Jul. No abstract available.

16.

The therapeutic properties of resminostat for hepatocellular carcinoma.

Zhao J, Gray SG, Wabitsch M, Greene CM, Lawless MW.

Oncoscience. 2018 Jun 23;5(5-6):196-208. doi: 10.18632/oncoscience.420. eCollection 2018 May.

17.

Exosomes: mediators of bone diseases, protection, and therapeutics potential.

Behera J, Tyagi N.

Oncoscience. 2018 Jun 23;5(5-6):181-195. doi: 10.18632/oncoscience.421. eCollection 2018 May. Review.

18.

Macrophages as prognostic biomarkers in human melanoma.

Samaniego R, Gutiérrez-Seijo A, Sánchez-Mateos P.

Oncoscience. 2018 Jun 30;5(5-6):179-180. doi: 10.18632/oncoscience.442. eCollection 2018 May. No abstract available.

19.

A mechanism for cell non-autonomous inactivation of the tumor suppressor DAB2IP.

Bellazzo A, Collavin L.

Oncoscience. 2018 Jun 29;5(5-6):177-178. doi: 10.18632/oncoscience.441. eCollection 2018 May. No abstract available.

20.

Efferocytosis and prostate cancer skeletal metastasis: implications for intervention.

Roca H, McCauley LK.

Oncoscience. 2018 Jun 29;5(5-6):174-176. doi: 10.18632/oncoscience.440. eCollection 2018 May. No abstract available.

Supplemental Content

Loading ...
Support Center